BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35095836)

  • 1. Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.
    Chen YT; Hsu HC; Lee YS; Liu H; Tan BC; Chin CY; Chang IY; Yang CY
    Front Immunol; 2021; 12():743448. PubMed ID: 35095836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
    Liu YY; Yang QF; Yang JS; Cao RB; Liang JY; Liu YT; Zeng YL; Chen S; Xia XF; Zhang K; Liu L
    Int J Cancer; 2019 Sep; 145(5):1423-1431. PubMed ID: 30664810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sequencing of CD4
    Wang L; Zhang P; Li J; Lu H; Peng L; Ling J; Zhang X; Zeng X; Zhao Y; Zhang W
    Arthritis Res Ther; 2019 Dec; 21(1):295. PubMed ID: 31856905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains.
    Kitaura K; Shini T; Matsutani T; Suzuki R
    BMC Immunol; 2016 Oct; 17(1):38. PubMed ID: 27729009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer.
    Cui JH; Lin KR; Yuan SH; Jin YB; Chen XP; Su XK; Jiang J; Pan YM; Mao SL; Mao XF; Luo W
    Front Immunol; 2018; 9():2729. PubMed ID: 30524447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition and diversity analysis of the TCR CDR3 repertoire in patients with idiopathic orbital inflammation using high-throughput sequencing.
    Fang Y; Shen B; Dai Q; Xie Q; Li X; Wu W; Wang M
    BMC Ophthalmol; 2023 Dec; 23(1):491. PubMed ID: 38044453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Cai G; Guan Z; Jin Y; Su Z; Chen X; Liu Q; Wang C; Yin X; Zhang L; Ye G; Luo W
    JCO Precis Oncol; 2022 Jan; 6():e2100120. PubMed ID: 35025620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor repertoires of ex vivo-expanded tumor-infiltrating lymphocytes from breast cancer patients.
    Park IA; Rajaei H; Kim YA; Lee H; Lee H; Seo JH; Heo SH; Song IH; Gong G; Lee HJ
    Immunol Res; 2020 Oct; 68(5):233-245. PubMed ID: 32886262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma.
    Guo L; Bi X; Li Y; Wen L; Zhang W; Jiang W; Ma J; Feng L; Zhang K; Shou J
    J Pathol; 2020 May; 251(1):26-37. PubMed ID: 32073142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.
    Miyasaka A; Yoshida Y; Wang T; Takikawa Y
    Hum Vaccin Immunother; 2019; 15(11):2738-2753. PubMed ID: 30945971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
    Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
    J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR-Seq Identifies Distinct Repertoires of Distant-Metastatic and Nondistant-Metastatic Thyroid Tumors.
    Lan X; Cao J; Ye K; Zhang C; Zhang Q; Ge X; Wang C; Zhang C; Tai Z; Wei W; Huang Y; Yi X; Tan Z; Zheng C; Chen C; Zhu X; Wang J; Xu J; Zhu X; Ge M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32674137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing.
    Thapa DR; Tonikian R; Sun C; Liu M; Dearth A; Petri M; Pepin F; Emerson RO; Ranger A
    Arthritis Res Ther; 2015 May; 17(1):132. PubMed ID: 26001779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of T-cell receptor repertoire in patients with ankylosing spondylitis after biologic therapy.
    Liu WC; Chang CM; Zhang Y; Liao HT; Chang WC
    Int Immunopharmacol; 2024 Jan; 127():111342. PubMed ID: 38101220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes.
    Abbas HA; Reville PK; Jiang X; Yang H; Reuben A; Im JS; Little L; Sinson JC; Chen K; Futreal A; Garcia-Manero G
    Front Immunol; 2021; 12():659625. PubMed ID: 33912187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging.
    Kallemeijn MJ; Kavelaars FG; van der Klift MY; Wolvers-Tettero ILM; Valk PJM; van Dongen JJM; Langerak AW
    Front Immunol; 2018; 9():448. PubMed ID: 29559980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of the T cell receptor β chain complementarity-determining region 3 in peripheral blood of neonates with sepsis: an analysis based on immune repertoire sequencing.
    Huang XB; Ye SZ; Wu JW; Fu QS; Liu BH; Qiu HX; Cheng GQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Nov; 23(11):1154-1160. PubMed ID: 34753548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of T cell repertoire in peripheral blood of patients from type 2 diabetes with complication.
    Yin Y; Sheng Y; Gao S; Zhang J; Wang W; Liu Y; Xu T; Zhang Y
    BMC Immunol; 2024 Jan; 25(1):10. PubMed ID: 38297222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor.
    Ji S; Li J; Chang L; Zhao C; Jia R; Tan Z; Liu R; Zhang Y; Li Y; Yin G; Guan Y; Xia X; Yi X; Xu J
    Clin Transl Oncol; 2021 Aug; 23(8):1646-1656. PubMed ID: 33583004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of TCR repertoire diversity in colorectal cancer after Erbitux (cetuximab) in combination with chemotherapy.
    Luo W; He WT; Wen Q; Chen S; Wu J; Chen XP; Ma L
    Am J Cancer Res; 2014; 4(6):924-33. PubMed ID: 25520880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.